Royal Marsden NHS Foundation Trust: New Treatment Combination Shows Promising Results in Recurrent Head and Neck Cancer
October 27, 2026
October 27, 2026
LONDON, England, Oct. 27 (TNSxrep) -- The Royal Marsden National Health Service Foundation Trust issued the following news:
* * *
New treatment combination shows promising results in recurrent head and neck cancer
77 per cent of patients with HPV-unrelated recurrent and/or metastatic head and neck squamous cell carcinoma saw their tumours respond to the treatment
25 October 2026
A treatment combination including the targeted therap . . .
* * *
New treatment combination shows promising results in recurrent head and neck cancer
77 per cent of patients with HPV-unrelated recurrent and/or metastatic head and neck squamous cell carcinoma saw their tumours respond to the treatment
25 October 2026
A treatment combination including the targeted therap . . .